Forbes J M & CO LLP Axsome Therapeutics, Inc. Transaction History
Forbes J M & CO LLP
- $1 Billion
- Q1 2025
A detailed history of Forbes J M & CO LLP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 3,840 shares of AXSM stock, worth $386,649. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,840
Previous 3,840
-0.0%
Holding current value
$386,649
Previous $324,000
37.96%
% of portfolio
0.04%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$332 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$294 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$170 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98.3 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.32B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...